Skip to main content
All lobbying filings

FEDERATION OF STATE MEDICAL BOARDS

Lobbying for FEDERATION OF STATE MEDICAL BOARDS

 Filing 1st Quarter - Report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 14, 2026
Expenses
$110,000.00
What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 15
  • Agency for Healthcare Research & Quality (AHRQ)
  • Centers For Disease Control & Prevention (CDC)
  • Centers For Medicare and Medicaid Services (CMS)
  • Defense, Dept of (DOD)
  • Drug Enforcement Administration (DEA)
  • Food & Drug Administration (FDA)
  • Health & Human Services, Dept of (HHS)
  • Health Resources & Services Administration (HRSA)
  • HOUSE OF REPRESENTATIVES
  • Natl Institutes of Health (NIH)
  • Office of Natl Drug Control Policy (NDCP)
  • SENATE
  • Substance Abuse & Mental Health Services Administration (SAMHSA)
  • Veterans Affairs, Dept of (VA)
  • White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

 Bills named in this filing 1
 Lobbying activity 2
Health Issues

HR 2332 and S 1101, States Handling Access to Reciprocity for Employment (SHARE) Act, goal to streamline the process of interstate licensure for healthcare professionals by allowing state licensing authorities to access FBI criminal history record information for background checks. Additional issues include opioid misuse and diversion, telemedicine, artificial intelligence in healthcare, and access to care.

Labor Issues/Antitrust/Workplace

Physician workforce, active supervision of state agencies

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem